SCHEMBL7653477

SCHEMBL7653477

CN1CCN(C2=Nc3cc(Cl)ccc3Nc3sc4ccc(/C(=C\C(=O)O)C(=O)O)cc4c32)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 4/20 0.44
CHRM1 P11229 3/20 0.44
DRD2 P14416 3/20 0.44
DRD3 P35462 3/20 0.44
ADRA2A P08913 2/20 0.44
HTR2A P28223 2/20 0.44
HTR3E A5X5Y0 1/20 0.44
MEN1 O00255 1/20 0.44
CACNA1F O60840 1/20 0.44
HTR3B O95264 1/20 0.44
ABCB11 O95342 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
ADRB2 P07550 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
CHRM5 P08912 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666689 0.91 CHRM1 (0.46) CHRM1HRH1
SCHEMBL7676736 0.91 CHRM1 (0.36) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL7658335 0.90 CHRM1 (0.48) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL7665232 0.89 CHRM1 (0.37) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL7665227 0.89 CHRM1 (0.37) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL6998924 0.86 CHRM1 (0.38) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL6995745 0.79 DRD2 (0.61) DRD4CHRM1DRD2DRD3ADRA2A
Fumaric Acid SCHEMBL7671580 0.73 CHRM1 (0.41) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL6998224 0.72 DRD2 (0.53) DRD4CHRM1DRD2DRD3ADRA2A
SCHEMBL6991310 0.72 DRD2 (0.61) DRD4CHRM1DRD2DRD3ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455521-B1 PSYCHOLOGICAL DISORDERS; SIDE EFFECT REDUCTION MITSUBISHI PHARMA CORPORATION (JP) 2002-09-24 US disclosed
US-6271225-B1 PSYCHOLOGICAL DISORDERS WELFIDE CORPORATION (JP) 2001-08-07 US disclosed